Educational Grants

Alkermes Educational Grants

Click Here to Apply

Alkermes contributes to independent education by supporting educational grants. Our focus areas include educational activities with pragmatic approaches to improve patient care and public health in the domains of schizophrenia and opioid dependence. We expect to contribute to a better and expanded understanding of the underlying mechanisms of disease and their relevance to medications that address those characteristics, as well as the overall treatment in a broad sense that includes psychosocial methods.

Alkermes’ educational grant funds may not be used to support overhead expenses of the applicant or for any other institution affiliated with the applicant. Grant requests must be unsolicited, should typically have multiple funders, support education on a wide range of treatment options, not promote a particular medicine and must not provide nor promise to Alkermes any tangible benefit. If there will be faculty for the activity, please do not share faculty names with Alkermes in any of the documentation uploaded. If requesting honoraria payment for faculty, please include in your submission the hourly rate and anticipated number of hours to be worked. Alkermes will not support funding for meals, unless they are modest buffet meals, snacks or coffee that are made available to all attendees of the Educational Activity and where the identity of the Healthcare Participants who partake is not separately identifiable.

Educational Grants - Request For Proposals (RFPs)

Alkermes is committed to funding high-quality, independent, certified and effective medical education programs designed for healthcare professionals.

Alkermes is particularly interested in funding collaborative submissions between CME providers partnering with professional organizations of practitioners who focus on treatment of persons with opioid use disorder and serious mental illness, including schizophrenia. Requests must be submitted online by the accredited provider. Alkermes is accepting proposals for the following RFPs:

View Educational Grants - Request For Proposals (RFPs) Postcard here.

Request For Proposal: Schizophrenia (RFP# 2019-RFP-SZ-01)

  • Alkermes is looking to fund educational activities that evaluate clinical data of current and emerging antipsychotics, including their mechanisms of action, for the treatment of schizophrenia.
  • Educational activities must be accredited (CME/CE), and collaborations between medical societies, academic institutions, and medical education companies are encouraged.
  • Special attention will be given to programs that will reach audiences that are focused on treating persons with serious mental illnesses. Programs with additional funding sources are preferred.
  • Proposals must be submitted to our online portal between the dates May 1st – May 30th, 2019. Any proposal submitted before or after this window period will not be eligible for RFP consideration. Please reference “2019-RFP-SZ-01” in your Request Title.
  • Recipients will be selected by the Alkermes Grants Review Committee, and recipients will be notified in June 2019.

Request For Proposal: Opioid Use Disorder (RFP# 2019-RFP-AD-02)

  • Alkermes is looking to fund independent educational programs regarding best practices for the use of long-acting injectable medications for the treatment of opioid use disorder, including best practices around withdrawal management and initiating these medications in real-world settings to improve outcomes in patients. Priority will be given to programs that develop enduring materials and that identify best practices based on the consensus view of experts in the fields of opioid use disorder research and clinical practice. Educational activities must be accredited (CME/CE), and collaborations between medical societies, academic institutions, and medical education companies are encouraged.
  • Target audiences for this education include the addiction care team, including physicians, nurses, pharmacists and researchers. Programs with additional funding sources are preferred.
  • Proposals must be submitted to our online portal between the dates May 1st – May 30th, 2019. Any proposal submitted before or after this window period will not be eligible for RFP consideration. Please reference “2019-RFP-AD-02” in your Request Title.
  • Recipients will be selected by the Alkermes Grants Review Committee, and recipients will be notified in June 2019.

Who May Apply

Only US-based organizations may apply. Medical Education Grants may be awarded to (i) organizations qualified as nonprofit with tax exempt status under the U.S. Internal Revenue Code or (ii) for-profit organizations who are accredited continuing medical education providers.

How To Apply

Requests must be submitted online by the accredited provider. Submissions are due at least 90 days in advance of the activity date. If responding to a Request For Proposal (RFP), please reference the RFP# in your Request Title.

Areas of Interest for Medical Education Requests (Non-RFP)

Alkermes is interested in collaborative submissions between CME providers partnering with professional organizations of practitioners who focus on treatment of persons with serious mental illness, such as schizophrenia and addictive disorders. Examples might include proposals for CME activities for regional meetings of psychiatric or addiction practitioners, or partnering with professional nurse practitioner, case manager, or pharmacist societies in their CME efforts for their constituents.

Alkermes is currently accepting proposals that address the topic areas listed below.

Substance Use Disorders

  • Improving the understanding of comparative effectiveness data for the treatment of Opioid Use Disorder (OUD)
  • Increasing awareness and understanding of opioid use disorder, alcohol use disorder, and the medication treatment options
  • Integrating medication for the treatment of OUD or AUD into outpatient practice
  • Improving the awareness and understanding of long-acting injectable medications for the treatment of OUD
  • Increasing awareness of treatment guidelines for OUD and AUD
  • Reducing barriers to initiation of treatment and retention in treatment for patients with OUD and AUD

Schizophrenia

  • Understanding and implementing pharmacologic approaches to address suboptimal outcomes for persons with schizophrenia
  • Using patient-centered approaches for optimizing treatment of schizophrenia
  • Addressing why medications fail for the treatment of schizophrenia: non-engagement, nonresponse, nonadherence, and comorbidities

Major Depressive Disorder (MDD)*

*Please note, Alkermes is not awarding applications for MDD until the second half of 2019. Please plan accordingly.

  • Education on new understanding of the pathophysiology of MDD
  • Exploring existing and novel (e.g., non-monoamine) pharmacological mechanisms for MDD
  • Recognition and management of patients with MDD with an inadequate response to current antidepressant therapy

Educational grants will not be awarded to or for:

  • Individuals or a healthcare professional’s private practice
  • Any charity or foundation associated with or controlled by an individual healthcare professional or healthcare professional’s private practice
  • Organizations that discriminate on the basis of race, color, sex, sexual orientation, religion, age, national origin or disability
  • Fundraising event of a potential customer (e.g., treatment center or hospital) where the proceeds are being used to cover general operational and routine business costs
  • Events that have already occurred
  • Political organizations, campaigns and activities
  • Religious organizations or groups whose activities are primarily sectarian in purpose
  • Programs or proposals that supplement an organization’s income or offset its expenses in a manner that benefits, directly or indirectly, a physician’s compensation

Alkermes is committed to complying with all applicable regulations and codes pertaining to education grants. Alkermes follows the requirements of the Compliance Program Guidance for Pharmaceutical Manufacturers issued by the Department of Health and Human Services Office of the Inspector General (“OIG Guidelines”), the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (“PhRMA Code”), the FDA Guidance to Industry Supported Scientific and Educational Activities, and the Accreditation Council for Continuing Medical Education (“ACCME”) Standards for Commercial Support. Alkermes does not provide support for education programs that are intended to encourage, induce, or influence any grant recipient to purchase, prescribe, refer, recommend, sell, administer, or arrange for the purchase, sale or recommendation, or formulary placement of any Alkermes’ product.

Application Requirements

Grant requests must be submitted at least 90 days prior to the activity start date. The following information is required for application submissions:

  • Grant Letter of Request
  • Activity Agenda
  • Activity Detailed Budget
  • Needs Assessment with references
  • Learning Objectives
  • Educational Outcomes Plan
  • Activity Description, including location of activity if relevant
  • Honoraria if applicable, including hourly rate and number of hours to be worked
  • Firewall policy if applicable
  • W9 form (current)
  • Accreditation Certificate(s)

Questions

Please contact Med.Ed@alkermes.com

To submit an educational grant request, please register and submit your completed application and supporting documentation through Alkermes’ educational grant management system located here.